BioPharma
06 February, 2026 | Friday | News
PepLib Biotech Enters Global Peptide Drug Discovery And Licensing Collaboration With Eli Lilly
Zonsen PepLib Biotech Inc. (“PepLib”) announced that it has entered a global research and development (R&D) collaboration and license agreement with Eli Lilly and Company ("Lilly"). Under the ag...
Lab
19 February, 2026 | Thursday | News
Waters Introduces 1 mm I.D. Microflow LC Columns With MaxPeak Premier Technology
Delivers up to 2× higher sensitivity than stainless steel microflow columns, lowering detection and quantitation limits across high-throughput bioseparations, DMPK, and 'omics applications. Uses u...
BioTech
10 February, 2026 | Tuesday | News
Waters BD Combination Creates A Scaled Global Platform For Regulated Diagnostics And Life Sciences
Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications Announces formation o...
Contract Services
13 February, 2026 | Friday | News
Syngene Partners With Johns Hopkins To Accelerate Early Stage Drug Discovery
Syngene International, a global contract research, development, and manufacturing organization (CRDMO) announced a strategic collaboration with Johns Hopkins University, MD, U.S., to advance early‑stage drug di...
Consumer Health
12 February, 2026 | Thursday | News
IFPA And WHO Foundation Launch Multi Year Alliance To Advance Global Psoriasis Care
The International Federation of Psoriasis Associations (IFPA) and the WHO Foundation have signed a multi-year collaboration agreement supporting WHO efforts to strengthen global understanding, diagnosis and car...
White Paper
17 February, 2026 | Tuesday | News
How Does GLP-1 Work?
Product Spot Light
19 February, 2026 | Thursday | News
Waters Introduces 1 mm I.D. Microflow LC Columns With MaxPeak Premier Technology
Premium Article
15 December, 2025 | Tuesday | Report
APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
Bio Invest
19 February, 2026 | Thursday | News
Pharmacelera Secures €6 Million To Expand US Footprint And Advance Quantum AI Drug Discovery Platform
Biopharma APAC Infomercial
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
